The team of cancer genetics experts that deciphered the genetic blueprints of cancer, have developed two new screening tests that have the promise to detect cancer in an early and curable stage. As the names of the tests indicate PapSEEK and UroSEEK, they seek out and find genetic evidence of cancer by detecting DNA released(...)
treatment
Geriatric Oncology: Cancer Care Coming of Age?
Posted by | caregiving, palliative care, treatmentThe American Cancer Society forecasts that nearly 1.7 million new cancer cases (more than 4,600 each day) and nearly 596,000 cancer deaths will occur in the United States in one year. An emerging driver of the cancer epidemic is the aging of the population. Read Kimmel Cancer Center director William Nelson’s editorial in Cancer Today,(...)
New Test Detects Eight Cancer Types
Posted by | Prevention/Screening, Research, treatmentMay make the most feared disease a little less scary Cancer is scary. Part of the reason—maybe even the main reason—cancer is so scary, is that it seems to come out of nowhere and changes lives in the blink of an eye. We’re feeling fine, but under the surface, hidden within the DNA of our(...)
Palliative Care: Putting a Cloak on Cancer
Posted by | caregiving, palliative care, treatmentPalliative care addresses symptoms and distress accompanying serious illnesses. The field is emerging as a vital medical specialty in the multidisciplinary treatment of cancer. Better access to expert palliative care for all cancer patients must be a priority. Read Kimmel Cancer Center director William Nelson’s editorial in Cancer Today, a publication of the American Association(...)
Cancer Interception: Kimmel Experts Part of New Stand Up To Cancer Project
Posted by | Research, treatmentStand Up To Cancer launched four new teams aimed at detecting and treating cancer in its earliest stages. Lung cancer expert Julie Brahmer, M.D., is the lead investigator for Johns Hopkins for lung cancer studies based at the Kimmel Cancer Center Thoracic Center of Excellence she directs. Victor Velculescu, M.D., Ph.D., an expert in the(...)
A New Issue of Breast Matters
Posted by | Patient Stories, precision medicine, Prevention/Screening, Research, Survivorship, treatmentThe latest issue of Breast Matters is now out on newsstands, and we have it here for you in our brand new digital design. The new issue includes news on our GAITWAY Tumor board, a group of more than a dozen experts who match treatments to the unique genetic characteristics of patients’ tumors. It also(...)
Immunotherapy for Lung Cancer
Posted by | precision medicine, treatmentIt’s lung cancer awareness month. Hear lung cancer expert Julie Brahmer and cancer genetics expert Victor Velculescu explain how immunotherapy is becoming a game changer for certain patients. Learn about the latest advances from our Bloomberg~Kimmel Institute for Cancer Immunotherapy and how we are helping patients with lung cancer live better and longer. Watch the(...)
Pancreatic Cancer Awareness Month
Posted by | Issues & Perspectives, treatmentIt’s Pancreatic Cancer Awareness Month, so we wanted to gather our best Kimmel Cancer Center resources for you. Learn more about cancer vaccines and other ways our experts are working to get the immune system to fight pancreatic cancer. Watch leading pancreatic cancer and immunology expert Elizabeth Jaffee, M.D., talk about new work from our(...)
What Every Lung Cancer Patient Needs to Know
Posted by | Research, treatmentIt’s lung cancer awareness month. “Many times patients come to us and they’ve been told they don’t have hope. We always have hope,” says Peggy Lang, nurse practitioner and coordinator of the Johns Hopkins Kimmel Cancer Center Thoracic Multidisciplinary Clinic and Lung Cancer Screening Program. In this video, she explains what every patient facing a(...)
Epigenetic Drugs Reset Genes in Breast, Colon Cancers But Didn’t Shrink Tumors
Posted by | Research, treatment--Two clinical trials suggest promise for using these medications in combination with other cancer therapies Two clinical trials using combinations of drugs meant to change cancer epigentics —or the way tumors express genes — failed at shrinking colon and breast tumors. However, these trials open the door for others currently in the works to combine(...)